Intended for healthcare professionals


Research funds should be returned if findings can’t be reproduced, proposes Merck chief

BMJ 2016; 353 doi: (Published 29 April 2016) Cite this as: BMJ 2016;353:i2477
  1. Susan Mayor
  1. London

Universities should return funding from the industry for research that proves to be non-reproducible, the chief medical officer of the drug company Merck has said in a proposal to reduce research that cannot be replicated by others.

“Recent studies have shown that the key findings in 50% or more of published reports in certain fields cannot be reproduced,” wrote Michael …

View Full Text

Log in

Log in through your institution


* For online subscription